Mortality and Attrition Rates within the First Year of Antiretroviral Therapy Initiation among People Living with HIV in Guangxi, China: An Observational Cohort Study

Table 1

Characteristics of PLHIV who started ART between 2003 and June 2015 in Guangxi, China.

Variable	Number	%
Total	58,115	—
Age (years)
18-34	18,358	31.6
35-49	19,290	33.2
50-70	17,457	30.0
≥70	3,010	5.2
Sex
Male	38,957	67.0
Female	19,158	33.0
Marital status
Married or cohabitation	40,224	69.2
Other	17,891	30.8
Route of HIV transmission
Heterosexual intercourse	49,608	85.4
Intravenous drug use	5,954	10.2
Homosexual intercourse	925	1.6
Other	1,628	2.8
CD4 cell count (cells/μL) before ART
<200	34,774	59.8
200-350	16,252	28.0
350-500	4,550	7.8
≥500	1,648	2.8
Missing	891	1.5
Initial ART regimen
The first-line ART containing D4T	14,244	24.5
The first-line ART containing AZT	23,059	39.7
The first-line ART containing TDF	13,965	24.0
The first-line ART containing LPV/r	4,510	7.8
Other	2,337	4.0
Level of ART site
Provincial	10,920	18.8
Prefecture	22,525	38.8
County	24,670	42.4
Year of ART initiation
2003-2008	7,741	13.3
2009-2011	17,800	30.6
2012-2015	32,574	56.1

ART: antiretroviral therapy; D4T: stavudine; AZT: azidothymidine; TDF: tenofovir; LPV/r: ritonavir-boosted lopinavir; HR: hazard ratio; AHR: adjusted hazard ratio.